论文部分内容阅读
目的:探讨脑脊液置换治疗蛛网膜下腔出血(SAH)的疗效及安全性。方法:53例蛛网膜下腔出血患者,随机分为两组。对照组27例接受常规治疗,治疗组26例在常规治疗的基础上行脑脊液置换。结果:治疗组临床症状或体征缓解情况优于对照组,临床有效率高于对照组。结论:脑脊液置换术+常规治疗治疗蛛网膜下腔出血优于单纯常规治疗,且安全性良好。
Objective: To investigate the efficacy and safety of cerebrospinal fluid replacement in the treatment of subarachnoid hemorrhage (SAH). Methods: 53 patients with subarachnoid hemorrhage were randomly divided into two groups. Control group, 27 cases received routine treatment, the treatment group of 26 patients on the basis of routine treatment of cerebrospinal fluid replacement. Results: The clinical symptom or symptom relief of the treatment group was better than that of the control group, and the clinical effective rate was higher than that of the control group. Conclusion: Cerebrospinal fluid replacement combined with conventional treatment of subarachnoid hemorrhage is better than simple conventional treatment and is safe.